Stay updated with breaking news from Evrys Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Intellectual Property (IP) Accelerator Fund provides support to researchers who have made a discovery but need to conduct extra studies to demonstrate that the discovery can meet a societal need.
/PRNewswire/ -- DelveInsight's Seasonal Influenza Market Insights report includes a comprehensive understanding of current treatment practices, seasonal...
The seasonal influenza market size is anticipated to increase in the coming years owing to the launch of the emerging therapies and vaccines. The current pipeline of seasonal influenza consists
/PRNewswire/ -- International Scientific Advisors (ISA), a tech-enabled marketplace that activates military veteran expertise to advance biomedical tech, has...
50+ active players in the domain working on 50+ pipeline therapies. Key Respiratory Syncytial Virus Infection Pipeline therapies such as RSV-F, V-306, CodaVax-RSV, mRNA-1345, MV-012-968, RV521, BARS13, EDP-938, MEDI8897, RSV MAT, RSVpreF, JNJ-53718678, RSV vaccine, ALVR106, V-306, CodaVax-RSV, mRNA-1345, Research program: sirtuin targeted therapeutics for respiratory viral infections and others are under different phases of clinical trials for Respiratory Syncytial Virus (RSV). Virometix, ReViral Ltd, Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. Codagenix, Inc, ModernaTX, Inc., Meissa Va...